• Targeted 177 Lu antisense radiotherapy of B-cell non-Hodgkin's lymphoma 

    Balkin, Ethan R., 1978- (University of Missouri-Columbia, 2011)
    The B-cell lymphoma/leukemia-2 (bcl-2) proto-oncogene in non-Hodgkin's lymphoma (NHL) is a dominant inhibitor of apoptosis. The research goal was to develop a 177Lu-labeled bcl-2 antisense peptide nucleic acid (PNA)-peptide ...